← Back to Search

Treatment for Scleroderma

N/A
Recruiting
Led By Robert F Spiera, MD
Research Sponsored by Hospital for Special Surgery, New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Individuals older than 18 years of age with Scleroderma
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline & follow-up visits during regularly scheduled appointments for up to 5 years
Awards & highlights

Summary

This trial is for a potential treatment for Scleroderma, a currently untreatable condition.

Eligible Conditions
  • Scleroderma

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline & follow-up visits during regularly scheduled appointments for up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline & follow-up visits during regularly scheduled appointments for up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Modified Rodnan Skin Score
Secondary outcome measures
Scleroderma Health Assessment Questionnaire
Short Form-36

Find a Location

Who is running the clinical trial?

Hospital for Special Surgery, New YorkLead Sponsor
249 Previous Clinical Trials
61,029 Total Patients Enrolled
Robert F Spiera, MDPrincipal InvestigatorHospital for Special Surgery, New York
2 Previous Clinical Trials
13 Total Patients Enrolled
Jessica K Gordon, MDPrincipal InvestigatorHospital for Special Surgery, New York
~67 spots leftby Jan 2030
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top